Table: Torii Pharmaceutical - Q1 parent results
Apr 26 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2018 Mar 31, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.93 13.61 60.70
(+2.4 pct) (-1.0 pct) (-5.4 pct)
Operating 769 mln 533 mln 3.50
(+44.2 pct) (-54.9 pct) (-44.3 pct)
Recurring 790 mln 555 mln 3.60
(+42.2 pct) (-54.6 pct) (-43.8 pct)
Net 569 mln 388 mln 2.60
(+46.4 pct) (-51.6 pct) (-44.9 pct)
EPS 20.29 yen 13.85 yen 92.70 yen
EPS Diluted 20.29 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)